Work

Brentuximab vedotin, an antibody-drug conjugate that targets CD30, for the treatment of patients with peripheral T-cell lymphoma

Year: 2014

Type: article

Source: 血液内科

Author: 大丸山

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2397103607

FWCI:

Cites:

Cited by:

Related to: 10